Hancock Jaffe Laboratories, Inc.

Hancock Jaffe Laboratories, Inc.

Hancock Jaffe Laboratories, Inc.

Overview
Date Founded

1999

Headquarters

70 Doppler,Irvine, CA 92614

Type of Company

Public

Employees (Worldwide)

12

Industries

Medical Products & Equipment
Hospitals & Patient Services

Company Description

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.

Contact Data
Trying to get in touch with decision makers at Hancock Jaffe Laboratories, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman of the Board & Chief Executive Officer

Chief Financial Officer

Chief Medical Officer & Senior Vice President

Executive Officer

Chief Medical Officer-Outside of United States

Board of Directors

Chairman of the Board & Chief Executive Officer at Hancock Jaffe Laboratories, Inc.

Chief of Staff at University of California San Diego Health System

Vice President at Eagle Manufacturing Group

Partner at K-5 Ventures LLC

Former Director-Global Marketing at Medtronic, Inc.

Paths to Hancock Jaffe Laboratories, Inc.
Potential Connections via
Relationship Science
You
Hancock Jaffe Laboratories, Inc.
Recent Transactions
Details Hidden

Hancock Jaffe Laboratories, Inc. issued USD Units Consisting of Common Stock and Warrants

Details Hidden

Hancock Jaffe Laboratories, Inc. raised money in a private placement transaction

Details Hidden

Hancock Jaffe Laboratories, Inc. raised money in a private placement transaction

Transaction Advisors
Auditor

Advised onHancock Jaffe Laboratories, Inc. issued USD Units Consisting of Common Stock and Warrants

Investment Advisor

Advised onHancock Jaffe Laboratories, Inc. raised money in a private placement transaction

Escrow Agent

Advised onHancock Jaffe Laboratories, Inc. issued USD Units Consisting of Common Stock and Warrants

Head of Investment Banking & Chairman

Advised onHancock Jaffe Laboratories, Inc. issued USD Units Consisting of Common Stock and Warrants

Legal Advisor

Advised onHancock Jaffe Laboratories, Inc. issued USD Units Consisting of Common Stock and Warrants

Clients

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Key Stats and Financials As of 2019
Market Capitalization
$7.08M
Total Enterprise Value
$8.22M
Earnings Per Share
$-12.1
Net Profit
$-7.63M
EBITDA
$-6.69M
EBITDAMargin
-21.4K%
Total Debt
$857K
Total Equity
$990K
Enterprise Value / Sales
263.02x
TEVNet Income
-1.08x
Debt TEV
0.1x
Three Year Compounded Annual Growth Rate Of Revenue
-65.87%
Five Year Compounded Annual Growth Rate Of Revenue
-33.29%
Revenue
$31.2K
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hancock Jaffe Laboratories, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hancock Jaffe Laboratories, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Hancock Jaffe Laboratories, Inc..